Pharmacological targeting of apelin impairs glioblastoma growth-Reference-Cited by-同舟云学术

Pharmacological targeting of apelin impairs glioblastoma growth

Published:2017-10-03 Issue:11 Volume:140 Page:2939-2954
ISSN:0006-8950
Container-title:Brain
language:en
Short-container-title:

Author:

Harford-Wright Elizabeth¹²,Andre-Gregoire Gwennan¹,Jacobs Kathryn A¹,Treps Lucas²,Le Gonidec Sophie³,Leclair Heloise M¹²,Gonzalez-Diest Sara¹²,Roux Quentin¹,Guillonneau François⁴,Loussouarn Delphine⁵⁶,Oliver Lisa⁵⁶,Vallette François M⁶⁷,Foufelle Fabienne⁸,Valet Philippe³,Davenport Anthony P⁹,Glen Robert C¹⁰¹¹,Bidere Nicolas¹²,Gavard Julie¹²

Affiliation:

1. CRCINA, Inserm, Team SOAP, CNRS, Universite de Nantes, Nantes, France

2. Institut Cochin, Team SOAP, Inserm, CNRS, Universite Paris Descartes, Paris, France

3. I2MC, Inserm, Universite Paul Sabatier, Toulouse, France

4. 3P5 Proteomics Facility of the Universite Paris Descartes, Paris, France

5. Centre Hospitalier Universitaire (CHU) de Nantes, Nantes, France

6. CRCINA, Inserm, Universite de Nantes, Nantes, France

7. Institut de Cancérologie de l’Ouest, René Gauducheau, St Herblain, France

8. Centre de Recherches des Cordeliers, Inserm, Universite Paris Descartes, Paris, France

9. Experimental Medicine and Immunotherapeutics, University of Cambridge, Cambridge, UK

10. The Centre for Molecular Informatics, Department of Chemistry, University of Cambridge, Cambridge, UK

11. Computational and Systems Medicine, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, UK